A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R

Clinical trial NCT02079805 · COMPLETED

Trial details

NCT number: NCT02079805
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Essential Hypertension Complicated by Type 2 Diabetes Mellitus

Start date: 2014-06-01
Primary completion: 2016-04-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.